Skip to content
Home » Tesla stock falls on Elon Musk drug use report, price target cut

Tesla stock falls on Elon Musk drug use report, price target cut

    Tesla (TSLA) stock is under pressure today following allegations that CEO Elon Musk pressured board members into drug use, according to a Wall Street Journal report. This follows a Delaware judge ruling Tesla's board process for approving Musk's massive pay package was "deeply flawed," prompting concerns about his relationships with individuals of his executive board. The troubling revelations about board oversight come as Tesla faces numerous headwinds including SAP SE (SAP) halting the use of Tesla as company cars and Piper Sandler's decision to cut it's price target on the stock. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Angel Smith

    Read full NASCAR article on Yahoo Sports

    Read all NASCAR articles